期刊文献+

运用Markov模型进行药物经济学评价的概率敏感度分析 被引量:5

Probabilistic sensitivity analysis of pharmacoeconomics research based on Markov model
原文传递
导出
摘要 概率敏感度分析是用统计途径估计药物经济学评价中不确定性的方法,其结果用成本-效果可接受曲线总体直观给出支持干预方式具有成本-效果的依据。本文介绍常用敏感度分析方法并用实例详细阐述概率敏感度分析过程,为规范运用Markov模型进行药物经济学研究提供参考依据。 Probabilistic sensitivity analysis was a statistical approach to handing uncertainty in pharmacoeconomics evaluation, and its results could be showed as a cost-effectiveness acceptability curve, which directly summarized the evidence in favor of the intervention being cost effective. In order to give a reference for doing pharmacoeconomics research based on Markov model correctly, sensitivity analysis was recommended and probabilistic sensitivity analysis was interpreted detailedly by an example.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2009年第3期175-178,共4页 Chinese Journal of New Drugs and Clinical Remedies
关键词 模型 统计学 经济学 药学 概率 敏感度分析 models, statistical economics, pharmaceutical probability sensitivity analysis
  • 相关文献

参考文献14

  • 1BUXTON M J, DRUMMOND MF, van HOUT BA, et al. Modelling in economic evaluation : an unavoidable fact of life[J]. Health Econ, 1997, 6(3): 217-227.
  • 2EDDY DM. Technology assessment: the role of mathematical modellin[M]//MOSTELLER F, editor. Assessing medical technologies. Washington, DC: National Academy Press, 1985: 144- 153.
  • 3BRIGGS AH. Handling uncertainty in cost-effectiveness models [J]. Pharmacoeconomics, 2000, 17(5): 479-500.
  • 4SONNENBERG FA, BECK JR. Markov models in medical decision making: a practical guide [J]. Med Decis Making, 1993, 13(4): 322-338.
  • 5徐端正.药物经济学及其分析[J].中国新药与临床杂志,2000,19(2):139-142. 被引量:487
  • 6Australian Commonwealth Department of Human Services and Health. Guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee: including major submissions involving economic analysis [M]. Canberra: Australian Government Publishing Service, 2002: 39.
  • 7DRUMMOND MF, JEFFERSON TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ [J]. BMJ, 1996, 313(7052): 275-283.
  • 8Canadian Coordinating Office for Health Technology Assessment. Guidelines for the economic evaluation of pharmaceuticals: Canada[M]. 2nd ed. Ottawa: Canadian Coordinating Office for Health Technology Assessment(CCOHTA), 1997: 47.
  • 9邱家学,李娜.我国药物经济学研究中存在的问题与思考[J].齐鲁药事,2006,25(8):458-460. 被引量:5
  • 10O'BRIEN B J, BRIGGS AH. Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods[J]. Stat Methods Med Res, 2002, 11 (6): 455-468.

二级参考文献6

共引文献490

同被引文献48

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部